Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Paredes

Showing results (71-80 of 309) with videos related to

Pageof 31
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2018
Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA PanelHuldrych F Günthard, Vincent Calvez, Roger Paredes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2018
Reply to Ambrosioni et alHuldrych F Günthard, Vincent Calvez, Roger Paredes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2009
Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathologySebastian Videla, Laila Darwich, Maria Paz Cañadas, et al.
Plos One|February 8, 2014
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch studyPatricia Echeverría, Anna Bonjoch, Jordi Puig, et al.
AIDS Research and Human Retroviruses|September 12, 2019
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 InfectionMarta Boffito, Laura Waters, Pedro Cahn, et al.
International Urology and Nephrology|December 19, 2021
Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot studyAna Merino-Ribas, Ricardo Araujo, Ioana Bancu, et al.
Topics in Antiviral Medicine|November 14, 2022
2022 update of the drug resistance mutations in HIV-1Annemarie M Wensing, Vincent Calvez, Francesca Ceccherini-Silberstein, et al.
Topics in Antiviral Medicine|October 22, 2019
2019 update of the drug resistance mutations in HIV-1Annemarie M Wensing, Vincent Calvez, Francesca Ceccherini-Silberstein, et al.
Open Forum Infectious Diseases|June 12, 2026
Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1Jean-Michel Molina, Chloe Orkin, Roger Paredes, et al.
Plos One|May 24, 2011
Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjectsFrancisco M Codoñer, Christian Pou, Alexander Thielen, et al.
Pageof 31

Showing results (71-80 of 309) with videos related to

Sort By:
Pageof 31
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2018
Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA PanelHuldrych F Günthard, Vincent Calvez, Roger Paredes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2018
Reply to Ambrosioni et alHuldrych F Günthard, Vincent Calvez, Roger Paredes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2009
Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathologySebastian Videla, Laila Darwich, Maria Paz Cañadas, et al.
Plos One|February 8, 2014
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch studyPatricia Echeverría, Anna Bonjoch, Jordi Puig, et al.
AIDS Research and Human Retroviruses|September 12, 2019
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 InfectionMarta Boffito, Laura Waters, Pedro Cahn, et al.
International Urology and Nephrology|December 19, 2021
Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot studyAna Merino-Ribas, Ricardo Araujo, Ioana Bancu, et al.
Topics in Antiviral Medicine|November 14, 2022
2022 update of the drug resistance mutations in HIV-1Annemarie M Wensing, Vincent Calvez, Francesca Ceccherini-Silberstein, et al.
Topics in Antiviral Medicine|October 22, 2019
2019 update of the drug resistance mutations in HIV-1Annemarie M Wensing, Vincent Calvez, Francesca Ceccherini-Silberstein, et al.
Open Forum Infectious Diseases|June 12, 2026
Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1Jean-Michel Molina, Chloe Orkin, Roger Paredes, et al.
Plos One|May 24, 2011
Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjectsFrancisco M Codoñer, Christian Pou, Alexander Thielen, et al.
Pageof 31